Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2018
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2018
- December 20181 results available
- November 20182 results available
- October 20181 results available
- September 20182 results available
- August 20183 results available
- July 20181 results available
- June 20187 results available
- May 20181 results available
- March 20182 results available
- February 20182 results available
Displaying 1 - 15 of 22 items.
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
AlertInformation update | 2018-11-28
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
AlertHealth professional risk communication | 2018-11-08
Health Canada reminds Canadians of the risks of decorative contact lenses
AlertInformation update | 2018-10-12
Health Canada reminds Canadians to consult a health professional before using high-concentration hydroquinone products
AlertInformation update | 2018-09-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
EpiPen (epinephrine USP) Auto-Injector - Interim Order allowing the importation of AUVI-Q in response to shortages of EpiPen and EpiPen Jr
AlertHealth professional risk communication | 2018-08-29
Drug and Alcohol Use During Orientation Week
AlertInformation update | 2018-08-20
Expansion of recall of valsartan drugs to include additional lots, as a precaution
AlertInformation update | 2018-08-18
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles
AlertHealth professional risk communication | 2018-07-17
Health Canada reminds Canadians of the limitations of fentanyl test strips being used to check street drugs before consumption
AlertInformation update | 2018-06-22
Drug Use During Festival Season
AlertInformation update | 2018-06-22
BLINCYTO (blinatumomab) and Benzyl Alcohol Toxicity for Pediatric Patients
AlertHealth professional risk communication | 2018-06-12
TIVICAY, TRIUMEQ and JULUCA (dolutegravir containing medicines) – Possible Risk of Neural Tube Defects
AlertHealth professional risk communication | 2018-06-07
Jamp-Glucose 50 and Jamp-Glucose 75 – Risk of False Negative Oral Glucose Challenge or Tolerance Test Results
AlertHealth professional risk communication | 2018-06-07